NewsInsights revealed into rheumatologist-patient discussions about biologicsAuthor:Nick Andrews Publish date: February 4, 2018An ethnographic, observational study analyzes discussions between rheumatologists and patients about starting biologics. Read More
NewsTisagenlecleucel looks effective in phase 2 study of young ALL patientsAuthor:Nick Andrews Publish date: January 31, 2018Tisagenlecleucel had transitory but high-grade toxicity in this population of children and young adults. Read More
NewsImmunotherapy with less intense chemotherapy safe and effective for older patients with ALLAuthor:Nick Andrews Publish date: January 21, 2018Immunotherapy with less chemotherapy appears effective for a neglected ALL patient subgroup: those aged 60 years and older. Read More
NewsHIPEC shows survival benefit for advanced ovarian cancerAuthor:Nick Andrews Publish date: January 17, 2018Hyperthermic intraperitoneal chemotherapy showed survival benefit without increasing risk for side effects in phase 3 study. Read More
